AMRX
Amneal Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$17.44
−2.41%Forward multiples
Based on analyst estimates
- P/E forward
- 17.59x
- P/E 2026E
- 17.48x
- P/E 2027E
- 15.18x
- P/E 2028E
- 12.27x
- P/S forward
- 1.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- 35.06x
- PEG TTM
- 0.36x
- Price / book
- 168.65x
- Price / sales
- 1.79x
- Price / cash flow
- 27.74x
Enterprise value
- Enterprise value
- $8.3B
- EV / sales
- 2.67x
- EV / EBITDA
- 12.75x
- EV / EBIT
- 20.63x
- Market cap
- $5.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026